Department of Thyroid and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Department of Endocrinology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Endocrine. 2024 Nov;86(2):813-823. doi: 10.1007/s12020-024-03964-4. Epub 2024 Jul 14.
Ectopic parathyroid carcinoma (EPC) is a rare clinical entity with multiple diagnostic pitfalls, making surgical cures challenging. We assessed the clinicopathological spectrum and outcome of EPCs.
In this retrospective cohort study, 24 EPCs were identified from 133 PC patients treated at a tertiary referral center. The relationship between clinicopathological findings and locations was analyzed.
The locations of EPCs were predominantly intrathyroidal (62.5%), followed by 16.7% in the mediastinum, 8.3% in the retropharyngeal space, 8.3% in the carotid sheath, and 4.2% in the upper neck. Intrathyroidal EPC patients experienced higher serum calcium (p = 0.020), a higher rate of vascular invasion (p = 0.040), and a slightly higher incidence of non-R0 initial resection (p = 0.092) than those in other ectopic locations. Intrathyroidal EPC patients also suffered a trend of higher upper aerodigestive tract (UAT) invasion rate (p = 0.070) and higher risks of distant metastasis (p = 0.037) than the other PC patients. The 5-year disease-free survival rate after surgery was slightly compromised at 41.5% in intrathyroidal EPC patients compared with 77.8% among those in other ectopic locations (p = 0.143) and 59.7% among the other PC patients (log-rank = 3.194; p = 0.074), though without statistical significance.
Intrathyroidal EPC might cause a more biochemically and invasively distinct PC picture compared with other PCs. Special caution should be exercised in the preoperative diagnosis and management of such cases.
甲状旁腺癌(EPC)是一种罕见的临床实体,存在多种诊断陷阱,使手术治愈具有挑战性。我们评估了 EPC 的临床病理谱和结局。
在这项回顾性队列研究中,从一家三级转诊中心治疗的 133 例甲状旁腺癌患者中确定了 24 例 EPC。分析了临床病理发现与位置之间的关系。
EPC 的位置主要位于甲状腺内(62.5%),其次是纵隔(16.7%)、咽后间隙(8.3%)、颈动脉鞘(8.3%)和颈上部(4.2%)。甲状腺内 EPC 患者的血清钙水平更高(p=0.020)、血管侵犯率更高(p=0.040)和初始非 R0 切除率略高(p=0.092),而其他异位位置的患者则较低。甲状腺内 EPC 患者的上呼吸道(UAT)侵犯率也有升高趋势(p=0.070),远处转移的风险也更高(p=0.037),但与其他甲状旁腺癌患者相比,差异无统计学意义。甲状腺内 EPC 患者手术后 5 年无病生存率为 41.5%,明显低于其他异位位置患者的 77.8%(log-rank=3.194,p=0.074)和其他甲状旁腺癌患者的 59.7%,但差异无统计学意义。
与其他 PCs 相比,甲状腺内 EPC 可能导致更具生化和侵袭性的 PC 特征。在这些病例的术前诊断和管理中应特别小心。